X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs MYLAN (US) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   MYLAN
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
MYLAN
Dec-14
STERLING BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs114,053-   
Low Rs32,856-   
Sales per share (Unadj.) Rs26.81,387.6-  
Earnings per share (Unadj.) Rs-15.0167.2-  
Cash flow per share (Unadj.) Rs-5.5269.1-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9689.8-  
Shares outstanding (eoy) m267.87378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x0.32.5 10.4%   
Avg P/E ratio x-0.520.7 -2.2%  
P/CF ratio (eoy) x-1.312.8 -9.9%  
Price / Book Value ratio x0.15.0 2.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8621,307,233 0.1%   
No. of employees `0001.425.0 5.4%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.321,001.5 25.3%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.02,530.0 -117.0%   
INCOME DATA
Net Sales Rs m7,181525,037 1.4%  
Other income Rs m43-3,060 -1.4%   
Total revenues Rs m7,223521,977 1.4%   
Gross profit Rs m947130,579 0.7%  
Depreciation Rs m2,54338,562 6.6%   
Interest Rs m4,37722,647 19.3%   
Profit before tax Rs m-5,93166,310 -8.9%   
Minority Interest Rs m0-272 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9242,788 -69.0%   
Profit after tax Rs m-4,00763,249 -6.3%  
Gross profit margin %13.224.9 53.0%  
Effective tax rate %32.44.2 771.6%   
Net profit margin %-55.812.0 -463.2%  
BALANCE SHEET DATA
Current assets Rs m14,335461,577 3.1%   
Current liabilities Rs m49,809360,861 13.8%   
Net working cap to sales %-494.019.2 -2,575.4%  
Current ratio x0.31.3 22.5%  
Inventory Days Days40378 516.7%  
Debtors Days Days171107 159.1%  
Net fixed assets Rs m55,432121,466 45.6%   
Share capital Rs m26818,567 1.4%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,701260,995 5.6%   
Long term debt Rs m9,478389,901 2.4%   
Total assets Rs m73,9881,051,265 7.0%  
Interest coverage x-0.43.9 -9.0%   
Debt to equity ratio x0.61.5 43.2%  
Sales to assets ratio x0.10.5 19.4%   
Return on assets %0.58.2 6.1%  
Return on equity %-27.324.2 -112.5%  
Return on capital %-6.413.6 -47.2%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,71969,017 2.5%  
From Investments Rs m-3,148-54,428 5.8%  
From Financial Activity Rs m1,426-18,186 -7.8%  
Net Cashflow Rs m-3-3,598 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 68.01 Rs / USD

Compare STERLING BIOTECH With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: TORRENT PHARMA  ORCHID PHARMA LTD  J.B.CHEMICALS  DR. REDDYS LAB  WOCKHARDT LTD.  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Jun 18, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS